Bcl-2 Active human, recombinant, expressed in E. coli, >=80% (SDS-PAGE)

Code: srp0186-100ug D2-231

Not available outside of the UK & Ireland.

Application

Useful for the study of apoptosis, screening inhibitors and selectivity profiling.

Biochem/physiol Actions

B-cell lymphoma 2 (BCL-2) ...


read more

Your Price
$670.02 100UG

Not available outside of the UK & Ireland.

Application

Useful for the study of apoptosis, screening inhibitors and selectivity profiling.

Biochem/physiol Actions

B-cell lymphoma 2 (BCL-2) inhibits apoptosis in cells and has been shown to be upregulated in adenomas.

General description

B-cell lymphoma 2 (BCL-2) is an anti-apoptotic and target gene of nuclear factor-κB (NF-κB). The protein is expressed in the nuclear envelope, mitochondria and endoplasmic reticulum. The gene encoding BCL-2 is localized on human chromosome 18q21. Human Bcl-2 (amino-acids 1-211) (GenBank Accession No. P10415) with C-terminal His tag, MW = 27 kDa, expressed in an E. coli expression system.

Physical form

Formulated in 25 mM Tris-HCl, pH 8.0, 100 mM NaCl, 0.05% Tween-20, 30% glycerol and 3 mM DTT.

Preparation Note

Thaw on ice. Upon first thaw, briefly spin tube containing enzyme to recover full content of the tube. Aliquot enzyme into single use aliquots. Store remaining undiluted enzyme in aliquots at -70°C. Note: Enzyme is very sensitive to freeze/thaw cycles.

assay≥80% (SDS-PAGE)
biological sourcehuman
concentration>0.02 mg/mL
formaqueous solution
Gene Informationhuman ... BCL2(596)
mol wt27 kDa
NCBI accession no.P10415
packagingpkg of 100 µg
recombinantexpressed in E. coli
shipped indry ice
storage conditionavoid repeated freeze/thaw cycles
storage temp.−70°C
This product has met the following criteria: